Physician profile
Sidney A Gottlieb
NPI 1588789762
$1,280.52
in general payments reported to CMS, 2019-2025
16 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $69.42 · 2021: $107 · 2022: $37.38 · 2023: $254 · 2024: $301 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $275.20 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $176.30 | 2019-2021 | |
| Alcon Vision LLC | $136.42 | 2022-2025 | Rhopressa, Rocklatan, Simbrinza |
| Horizon Therapeutics Plc | $102.40 | 2023 | Tepezza |
| Dompe US, INC. | $89.82 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $87.18 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $79.84 | 2023-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $73.26 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Allergan, INC. | $69.42 | 2020 | |
| Astellas Pharma US INC | $38.21 | 2024 | Izervay |
| Coopervision INC. | $33.22 | 2023-2025 | Myday Contact Lens, Clariti Contact Lens |
| Mallinckrodt Hospital Products INC. | $27.95 | 2021 | |
| Glaukos Corporation | $25.90 | 2023 | |
| Rxsight INC | $25.46 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $22.27 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $17.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidney Gottlieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.